Scholars Central

Short communicationPublished 21 Mar 2017

Selected Probiotic Bacteria and Short Chain Fatty Acids Delay the Pathogenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma

Authors: Mark Feitelson

Global Journal of Molecular Evolution and Genomic

Volume 5 · Issue 1 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Chronic infection with hepatitis B virus (HBV) is associated with the development of progression of chronic liver disease (CLD) and the appearance of hepatocellular carcinoma (HCC). HCC is a prevalent cancer worldwide with few treatment options. Most of the treatments available are for patients with advanced cancer, and the results have been very modest because these are the patients most difficult to treat. A different way of thinking involves recognizing and reducing the risk factors that contribute to the pathogenesis of HCC. Given that HCC develops decades after HBV infection, and appears most often on the background of chronic inflammation, experiments were designed to test the hypothesis that selected probiotic bacteria and bacterial metabolites that mediate immunomodulation, by suppressing inflammation, could be used as a simple, readily available, and inexpensive means to target CLD so as to prevent or delay the appearance of HCC.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Global Journal of Molecular Evolution and Genomic.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalGlobal Journal of Molecular Evolution and Genomic
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Mark Feitelson”